2021
DOI: 10.1021/acsnano.1c04280
|View full text |Cite
|
Sign up to set email alerts
|

Upconverted Metal–Organic Framework Janus Architecture for Near-Infrared and Ultrasound Co-Enhanced High Performance Tumor Therapy

Abstract: Strict conditions such as hypoxia, overexpression of glutathione (GSH), and high concentration of hydrogen peroxide (H2O2) in the tumor microenvironment (TME) limit the therapeutic effects of reactive oxygen species (ROS) for photodynamic therapy (PDT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT). Here we fabricated a biocatalytic Janus nanocomposite (denoted as UPFB) for ultrasound (US) driven SDT and 808 nm near-infrared (NIR) light mediated PDT by combining core–shell–shell upconversion nanopa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
129
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 182 publications
(129 citation statements)
references
References 65 publications
0
129
0
Order By: Relevance
“…Recently, Lin group designed and synthesized UCNP‐MOF Janus structures (UPFB) for synergistic tumor therapy including PDT, chemodynamic therapy (CDT), and sonodynamic therapy (SDT) ( Figure a). [ 108 ] In this work, ultrasound was selected as an exogenous energy source for activation of UPFB to heighten ROS generation, which made up for the inefficient PDT caused by low energy transfer in the heterodimers. Besides, Fe 3+ ions coordinated in porphyrin‐based PCN‐224(Fe) MOFs served as catalase‐like nanozymes, which not only catalyzed the decomposition of H 2 O 2 to O 2 to alleviate tumor hypoxia (Figure 12b), but also suppressed other pathways consuming generated ROS by intracellular GSH depletion.…”
Section: Biomedical Applications Of Ucnp‐mof Heterostructuresmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, Lin group designed and synthesized UCNP‐MOF Janus structures (UPFB) for synergistic tumor therapy including PDT, chemodynamic therapy (CDT), and sonodynamic therapy (SDT) ( Figure a). [ 108 ] In this work, ultrasound was selected as an exogenous energy source for activation of UPFB to heighten ROS generation, which made up for the inefficient PDT caused by low energy transfer in the heterodimers. Besides, Fe 3+ ions coordinated in porphyrin‐based PCN‐224(Fe) MOFs served as catalase‐like nanozymes, which not only catalyzed the decomposition of H 2 O 2 to O 2 to alleviate tumor hypoxia (Figure 12b), but also suppressed other pathways consuming generated ROS by intracellular GSH depletion.…”
Section: Biomedical Applications Of Ucnp‐mof Heterostructuresmentioning
confidence: 99%
“…Reproduced with permission. [ 108 ] Copyright 2021, American Chemical Society. e) Schematic illustration of the preparation and bactericidal activity of UCNP@PCN@LA‐PVDF nanocomposites.…”
Section: Biomedical Applications Of Ucnp‐mof Heterostructuresmentioning
confidence: 99%
“…15 The high PS construction ratio, low self-quenching rate, efficient ROS diffusion, high drug loading rate and flexible modifiable sites make MOF photodynamic materials a highly promising multifunctional photodynamic nanotherapy platform. 16 However, relying solely on the photodynamic action of MOF PSs still has the disadvantages of poor curative effect, a tendency for recurrence and the need for repeated treatments for more malignant tumor types like oral cancer. Therefore, using a highly porous structure of MOFs to load drugs that have a synergistic effect with PDT will greatly improve the efficiency of combined therapy.…”
Section: Introductionmentioning
confidence: 99%
“…The common feature of all these strategies is that oxygen plays an essential role during the treatment processes. To further amplify the generation of ROS, extensive research has been aimed at designing O 2 -independent ROS production system to overcome hypoxia induced SDT resistance [ [24] , [25] , [26] , [27] , [28] ]. For instance, Zhang applied a Ti-TCPP MOF platform to generate ROS in a hypoxic environment and facilitate oxygen-independent SDT treatment [ 29 ].…”
Section: Introductionmentioning
confidence: 99%